New Molecular Targets for Cancer Chemotherapy
This book covers a wide range of novel biochemical targets that appear to be the best leads in terms of designing novel targets for anticancer drug design. New Molecular Targets for Cancer Chemotherapy is a unique, multi-disciplinary effort, with internationally respected authors from the fields of growth factor-receptor interaction, phosphoinositide and phospholipase signal transduction, and DNA-drug binding interactions. The science is placed in clinical context and illustrations explain how clinicians can incorporate a mechanistic, pharmacodynamic approach into early clinical trial design.
Comentarios de usuarios - Escribir una reseña
No hemos encontrado ninguna reseña en los sitios habituales.
An Overview of the Regulation of PhospholipaseLinked Cell Signaling
Growth Factor Receptors as Targets
Protein Tyrosine Kinase Inhibitors
Acad activity addition agents altered analogues antibodies apoptosis appears approach associated base binding Biochem Biol block c-myc Ca2+ Cancer Res caused cell death cells cellular changes Chem clinical complex compounds concentrations cytoplasmic cytotoxic demonstrated differentiation domain drug effects enzyme evidence example expression fibroblasts Figure function gene growth factor receptor human hydrolysis important increase induced inhibition inhibitors insulin receptor interaction intracellular involved lead levels lipid major malignant mechanism membrane molecular mutation Nature normal observed oncogene Oncology overexpression P-glycoprotein P-gp particular pathways patients PDGF phase phospholipase phosphorylation platelet-derived growth factor possible potential present Proc proliferation protein kinase recently regulation response role Science selective sequence SH2 domains shown signal transduction specific stimulation structure studies substrate suggested synthesis target therapeutic therapy transcription transformation trials tumor tyrosine kinase tyrphostins vincristine vitro